Log in to save to my catalogue

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individua...

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individua...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b762927158b6473fb74df8fd2f4621db

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

About this item

Full title

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

Publisher

Canada: JMIR Publications

Journal title

JMIR public health and surveillance, 2023-11, Vol.9, p.e50894

Language

English

Formats

Publication information

Publisher

Canada: JMIR Publications

More information

Scope and Contents

Contents

Emerging HIV drug resistance caused by increased usage of antiretroviral drugs (ARV) could jeopardize the success of standardized HIV management protocols in resource-limited settings.
We aimed to characterize pretreatment HIV drug resistance (PDR) among HIV-positive individuals and risk factors in China in 2022.
This cross-sectional study wa...

Alternative Titles

Full title

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b762927158b6473fb74df8fd2f4621db

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b762927158b6473fb74df8fd2f4621db

Other Identifiers

ISSN

2369-2960

E-ISSN

2369-2960

DOI

10.2196/50894

How to access this item